Immunoregulation by targeting T cells in the treatment of allergy and asthma

被引:52
作者
Larche, Mark
机构
[1] McMaster Univ, Dept Med, Div Allergy Immunol, Hamilton, ON L8N 3Z5, Canada
[2] Univ London Imperial Coll Sci Technol & Med, Fac Med, London SW7 2AZ, England
关键词
D O I
10.1016/j.coi.2006.09.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T-cell responses to allergens are crucial in determining the choice between health and disease. Th2 responses drive synthesis of IgE and the recruitment, maturation, survival and effector function of accessory cells such as eosinophils, basophils and mast cells. Allergen-specific strategies for targeting T-cell responses in established allergic diseases have been employed with success for almost a century. Recently, new insight into the mechanism of action of such approaches has revealed modulation of the delicate and complex regulatory mechanisms including suppression of Th2 responses through antagonistic Th1 responses and regulation through IL-10 and TGF beta production.
引用
收藏
页码:745 / 750
页数:6
相关论文
共 38 条
[1]   Role of interleukin 10 in specific immunotherapy [J].
Akdis, CA ;
Blesken, T ;
Akdis, M ;
Wüthrich, B ;
Blaser, K .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :98-106
[2]   IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy [J].
Akdis, CA ;
Blaser, K .
FASEB JOURNAL, 1999, 13 (06) :603-609
[3]   Epitope-specific T cell tolerance to phospholipase A(2) in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro [J].
Akdis, CA ;
Akdis, M ;
Blesken, T ;
Wymann, D ;
Alkan, SS ;
Muller, U ;
Blaser, K .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (07) :1676-1683
[4]   Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells [J].
Akdis, M ;
Verhagen, J ;
Taylor, A ;
Karamloo, F ;
Karagiannidis, C ;
Crameri, R ;
Thunberg, S ;
Deniz, G ;
Valenta, R ;
Fiebig, H ;
Kegel, C ;
Disch, R ;
Schmidt-Weber, CB ;
Blaser, K ;
Akdis, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (11) :1567-1575
[5]   Fel d 1-derived T cell peptide therapy induces recruitment of CD4+CD25+;: CD4+ interferon-γ+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects [J].
Alexander, C ;
Ying, S ;
Kay, AB ;
Larché, M .
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (01) :52-58
[6]   Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects [J].
Bellinghausen, I ;
Metz, G ;
Enk, AH ;
Christmann, S ;
Knop, J ;
Saloga, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) :1131-1139
[7]   A mutant of the major apple allergen, Mal d 1, demonstrating hypo-allergenicity in the target organ by double-blind placebo-controlled food challenge [J].
Bolhaar, STHP ;
Zuidmeer, L ;
Ma, Y ;
Ferreira, F ;
Bruijnzeel-Koomen, CAFM ;
Hoffmann-Sommergruber, K ;
van Ree, R ;
Knulst, AC .
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (12) :1638-1644
[8]   A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections [J].
Drachenberg, KJ ;
Wheeler, AW ;
Stuebner, P ;
Horak, F .
ALLERGY, 2001, 56 (06) :498-505
[9]   Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4(+) T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma [J].
Durham, SR ;
Ying, S ;
Varney, VA ;
Jacobson, MR ;
Sudderick, RW ;
Mackay, IS ;
Kay, AB ;
Hamid, OA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (06) :1356-1365
[10]   Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: Results of a phase I trial [J].
Fellrath, JM ;
Kettner, A ;
Dufour, N ;
Frigerio, C ;
Schneeberger, D ;
Leimgruber, A ;
Corradin, G ;
Spertini, F .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (04) :854-861